References
- Ellis JD, MacEwen CJ, Young JD. Can congenital nasolacrimal-duct obstruction interfere with visual development? A cohort case–control study. J. Pediatr. Ophthalmol. Strabismus.35(2), 81–85 (1998).
- Simon JW, Ngo Y, Ahn E, Khachikian S. Anisometropic amblyopia and nasolacrimal duct obstruction. J. Pediatr. Ophthalmol. Strabismus.46(3), 182–183 (2009).
- Piotrowski JT, Diehl NN, Mohney BG. Neonatal dacryostenosis as a risk factor for anisometropia. Arch. Ophthalmol.128(9), 1166–1169 (2010).
- Matta NS, Singman EL, Silbert DI. Prevalence of amblyopia risk factors in congenital nasolacrimal duct obstruction. J. AAPOS14(5), 386–388 (2010).
- Donahue SP, Arnold RW, Ruben JB; AAPOS Vision Screening Committee. Preschool vision screening: what should we be detecting and how should we report it? Uniform guidelines for reporting results of preschool vision screening studies. J. AAPOS7, 314–316 (2003).
- Puvanachandra N, Trikha S, MacEwen CJ, Morris RJ, Hodgkins PR. A national survey of the management of congenital nasolacrimal duct obstruction in the United Kingdom. J. Pediatr. Ophthalmol. Strabismus.47(2), 76–80 (2010).
- Matta NS, Silbert DI. High prevalence of amblyopia risk factors in preverbal children with nasolacrimal duct obstruction. J. AAPOS15(4), 350–352 (2011).
- Takahashi Y, Kakizaki H, Chan WO, Selva D. Management of congenital nasolacrimal duct obstruction. Acta. Ophthalmol.88(5), 506–513 (2010).